← Browse by Condition
Medical Condition

follicular lymphoma and marginal zone lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04110301 Phase 1, Phase 2
Recruiting

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

Enrollment
53 pts
Location
China
Sponsor
Beijing Mabworks Biotech Co., ...
View Trial →